Browse the evidence

There is a surge of interest in unimolecular peptide hormone-based polypharmacy for obesity management.

Practitioners should stay informed about developments in peptide hormone therapies for obesity.

Tirzepatide is a first in class dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (GIP) analog approved for the management of adult patients with type 2 diabetes mellitus.

Tirzepatide can be prescribed to adults with type 2 diabetes as part of their treatment plan.

Small-molecule GLP1RAs regulate both homeostatic and hedonic feeding through parallel neural circuits.

Practitioners can consider the dual impact of small-molecule GLP1RAs on different feeding behaviors.

GLP1RAs suppress the consumption of palatable foods by reducing dopamine release in the nucleus accumbens.

Understanding this mechanism can help in developing strategies to manage palatable food consumption.

Targeted deletion of the receptor in central amygdalar neurons diminishes the anorectic efficacy of GLP1RAs for reward-driven intake.

This finding highlights the importance of specific neural receptors in the effectiveness of weight loss drugs.

GIP(1-30)NH2 has similar effects on glucose and bone metabolism in healthy individuals as GIP(1-42).

GIP(1-30)NH2 may be considered a viable alternative to GIP(1-42) for influencing glucose and bone metabolism.

GIP(1-30)NH2 results in similar glucagonotropic and insulinotropic effects as GIP(1-42).

GIP(1-30)NH2 could be used similarly to GIP(1-42) in clinical settings for managing insulin and glucagon levels.

The 7-year cardiovascular risk was 17.4% in the surgery group with preoperative preparation and 18.8% in the no-surgery group, with a risk difference of -1.4.

Preoperative preparation combined with bariatric surgery does not significantly reduce cardiovascular risk.

The addition of a self-monitoring wearable device did not provide additional benefit for weight loss compared to the intervention workbook alone.

The use of wearable devices may not be necessary for weight loss interventions focused on eating behaviors.

Excessive consumption of industrial seed oils rich in linoleic acid contributes to mitochondrial dysfunction.

Reducing intake of linoleic acid-rich oils may be beneficial for mitochondrial health.

LA-induced mitochondrial perturbations are linked with gut dysbiosis.

Addressing mitochondrial health may also improve gut microbiome balance.

Strategic dietary modulation, particularly a marked reduction in LA intake, may restore mitochondrial redox homeostasis and improve metabolic health.

Reducing linoleic acid in the diet could enhance mitochondrial function and overall metabolic health.

Intestinally derived messengers, including gut hormones and microbial metabolites, regulate feeding behavior.

Understanding these signals can help in developing targeted obesity treatments.

Current anti-obesity medications primarily focus on increasing satiety and reducing appetite.

Practitioners should be aware of the current focus of obesity medications when considering treatment options.

Subgroup analyses showed no effect on results when stratifying studies according to combined SJ + MJ versus MJ training alone.

Combining SJ and MJ exercises does not show a distinct advantage in hypertrophy outcomes.

Current lipid-lowering drugs are being questioned for their usefulness and may be harmful.

Practitioners should critically evaluate the use of lipid-lowering drugs in their practice.

Sarcopenia is associated with 1.60 to 5.80 greater odds of activities of daily living (ADL) disability.

Practitioners should consider sarcopenia as a significant risk factor for ADL disability in older adults.

Agreement between methods of operationalizing grip strength is modest.

Practitioners should be cautious about the variability in grip strength measurements when assessing sarcopenia.

Plasma myristic acid, linoelaidic acid, linoleic acid, α-linoleic acid, pentadecanoic acid, alanine, proline, carnitine, and deoxycarnitine increased among participants following a Western diet.

These metabolites can indicate adherence to a Western diet and its potential health impacts.

The LLHR group demonstrated a trivial difference in fat free mass (FFM) favoring LLHR vs ST of 0.27 kg (95 % CI (-0.87, 1.42)).

Lighter load training may not significantly increase fat-free mass compared to traditional training.

Postoperative weight regain (WR) affects 20-30% of patients after bariatric surgery.

Clinicians should be aware that a significant portion of bariatric surgery patients may experience weight regain.

Weight regain is influenced by hormonal adaptations, including ghrelin rebound and leptin resistance.

Understanding hormonal influences can help in developing targeted interventions for weight management post-surgery.

There was a 100-fold increase in the prescription period prevalence of weight loss agents in the active component from their initial authorization date.

Practitioners should be aware of the significant increase in weight loss medication prescriptions among military personnel.

Service members in health care occupations and the Navy had higher prevalence of weight loss medication prescriptions compared to other service branches and occupations.

This information can inform targeted strategies for weight loss medication distribution within the military.